Information provided by Health Train Express and Digital Health Space is informational only. We do not endorse specific solutions. Inclusions are provided as reference only. Readers should consult with their own consultants for further details.


Friday, June 29, 2018

Don't worry Doc, I've got two


Our system is based on sickness, not health, so expensive procedures are favored over preventing those procedures from happening in the first place.

That statement from a recent patient was a summary to me of what is bad in our health care “system.”  It’s a terrible summary of what is seen all over this country with people who must make the choice between financial solvency and health.
Here’s what happened:  It was a new patient I saw, who is a veteran who owns two businesses.  He went out on his own when he “kept getting laid off.”  He has largely been successful in what he’s doing, but as is the case with many these days, he couldn’t afford health insurance.  This was especially bad because he had a heart attack last year, which required stenting and a significant hospital stay.  He didn’t fill me in on the financial details, but there’s no doubt that this hurt him significantly.
Unfortunately, he has another problem: glaucoma.  His glaucoma is bad enough to need surgery done to avoid losing vision in one eye.  Sadly, he can’t afford that surgery.  We talked about the difficult choices he had to make with his health and his money.  “It seems to me that the eye problem is the most urgent problem you have.  You don’t want to lose your vision,” I told him.
That’s when he smiled, waved his hand over his right eye and said, “Don’t worry, doc.  It’s just one eye.  I’ve got two.”


My stomach lurched to hear this statement.  A guy who has done nothing wrong aside from choosing self-employment (and perhaps inheriting less-than-stellar genes) is left with the choice: financial devastation or blindness in one eye.  He works hard, has served the country, didn’t complain to me at all, yet here he is about to be swallowed by the ever-widening maw of impossible medical expense.
How can we help people in this situation?  How can we care for those who need care without increasing already out of control spending?  There are many who give simplistic answers to that question, but most of them ignore the cause of our problems: the out-of-control cost of care.
As a retired ophthalmologist, this scenario seems all too real. The reality depends upon how old is the patient ?  Most patients who develop cataract are over 65 and qualify for Medicare reimbursement. Cataracts develop very gradually and can wait to be removed. However other serious conditions such as glaucoma and/or macular degeneration must be treated early to avoid permanent loss of eye sight.
There is no one single reason for medical financial stress, much of it depends upon the status of employment, disability or others, too numerous to mention.  There are circumstances where I  could waive a copay, however Medicare would penalize me for doing so. The rule is buried somewhere in my participating provider agreement with CMS.  If faced with the option of performing a surgery on a medicare payment, would I collect a copayment from a patient if necessary?  Would I refuse to treat a patient who did not pay a co-payment? No, I would not.  If read correctly the rule says that I should attempt to collect a co-payment at the time of visit.  My front office asks the patient for the co-payment. If they do not pay or cannot pay, it is waived. (quietly) . I am sure some physicians have been audited and warned.  Perhaps Medicare does not yell 'fraud' at this deception.  I expect the CMS budget, already stressed, could not afford to prosecute these 'misdemeanors'.  There is enough real fraud perpetrated. However, if the sum total amount exceeds $ 10,000 a perpetrator could be accused of a felony.
How can we help people in this situation?  How can we care for those who need care without increasing already out of control spending?  There are many who give simplistic answers to that question, but most of them ignore the cause of our problems: the out-of-control cost of care. My colleague who wrote the original article is a primary care physician (family medicine, ob/gyn, or internal medicine).  These physicians are at the gateway at the entry point to the health system. Ninety-nine percent of their patients do not require inpatient or complicated treatments.
My colleagues, as well as others, have developed a new model for medical expense.  
In his practice, which is (by the way) a direct primary care practice, where he does not accept payment from insurance companies but rather is paid by patients in the form of a low ($35 to $70) monthly payment.  Because he is paid directly by my patients, he is motivated to save them money whenever possible, as it justifies paying me the monthly fee.  Also, me being much less busy (I see between 5 and 12 patients on a normal day), he can work to find ways to avoid unnecessary care.  This is especially important because many of my patients don’t have insurance and those who do have high-deductible plans. Direct payment avoids almost all the overhead of having an insurance department and personel to collect payment.
This patient experienced this aspect of my care on this same visit.  He was also interested in being screened for colon cancer.  Some friends had urged him to do so.  “But when I called to find out what a colonoscopy costs, they said it would be more than $6,000!  I can’t afford that!”  I sent a quick message to my nurse and she relayed that there is a gastroenterologist in town who can do a colonoscopy for $1,600 (extra for biopsies, of course).
He was impressed by this, as are many of my patients when we do lab tests for more than 80 percent discount, dispense medications that are more than 70 percent cheaper than the average discounted price from GoodRx, and when we know where to get $100 ultrasounds, $250 CT scans, and $450 MRI scans.  These prices are out there for any doctor to use, but my business model makes it to my advantage to give patients the best value possible.  So there are ways to cut the cost of care for many people.  Unfortunately, not many doctors use these resources, much less know about them.  Few, if any specialists use this model of a deep discount for cash at the front desk.
A deeper question in this man’s case is the fact that his heart disease was treated at a local hospital which specializes in heart disease.  While much of the public may see this as a positive thing, those who know health care realize that these hospitals are very quick to do procedures that are not always necessary.  In his case, he had a stent placed on a 65 percent lesion, which doesn’t have great evidence supporting its placement.  Much of interventional cardiology treads the ground lightly in the area of solid epidemiological evidence of benefit for some very expensive procedures.  It seems to be based largely on the visceral response all of us (me included) would have: “It could only help to stent the 65 percent lesion, wouldn’t it?   What will it hurt?”  It turns out that the evidence for much of this is light.
In this case, the stenting of a 65 percent lesion could result in blindness, as the money he would have spent on eye surgery was instead paid to the interventional cardiologist and the “heart specialty” hospital.


Thursday, June 28, 2018

Online Pharmacy's have broken through the 'glass ceiling'




This morning Amazon broke the news that it is acquiring virtual pharmacy PillPack. With this, the online retail giant that has made itself famous for “one-click shopping” for consumer goods is positioning to expand its services to include prescription medication. 

Do you remember when ordering prescriptions from Canadian online pharmacies and ordering contract lenses online was considered  'UnAmerican?  Today if you are not purchasing items, medications, or dog food online you may be considered a  Luddite. 

The recent announcement that Berkshire Hathaway and Amazon would partner to improve health care and reduce cost is becoming a reality very quickly.

A week after appointing a CEO for its healthcare joint venture with Berkshire Hathaway and JPMorgan, Amazon  today announced an acquisition that underscores how it also hopes to have a more direct — and more commercial — role in the world of healthcare in the coming years. The company has purchased PillPack, an online pharmacy the lets users buy medications in pre-made doses.



The move (and that reported valuation hike) signal how heated the e-health market is becoming, and also how Amazon views it as a key frontier in its bid to be the go-to place for anything a consumer (or medical organization) might want or need in the area of healthcare.
The might of Amazon in commerce plays a massive role in how the market is poised to develop: it buying the company is not only a signal of how PillPack will likely get scaled out (not least through Amazon’s healthcare JV) but also because of how other pharmacy companies will have to respond. So far, the market is punishing the rest for not already being where Amazon appears to be going.
“PillPack’s visionary team has a combination of deep pharmacy experience and a focus on technology,” Jeff Wilke, CEO of Amazon Worldwide Consumer, said in a statement. “PillPack is meaningfully improving its customers’ lives, and we want to help them continue making it easy for people to save time, simplify their lives, and feel healthier. We’re excited to see what we can do together on behalf of customers over time.”
Amazon, Berkshire Hathaway and JPMorgan announced the eagerly-anticipated head of their joint venture on Wednesday: Atul Gawande, MD. 
Gawande has worn many hats over his distinguished career: surgeon at Brigham and Women’s Hospital, a professor at Harvard's T.H. Chan School of Public Health, staff writer at The New Yorker, best-selling author.
The precise nature of the new venture, which the three companies announced earlier this year, is still largely shrouded in mystery. It doesn't even have a name yet. 
But today three new facts emerged: It will be based in Boston. It will be an "independent entity that is free from profit-making incentives and constraints." And Gawande will lead it, starting on July 9. The New England-based startup delivers medications in pre-sorted dose packaging, coordinates refills and renewals, and ensures that shipments are sent on time, according to a statement. The service targets people who take multiple daily prescriptions. While terms of the deal have not yet been released,  
The synergy of Amazon and Berkshire Hathaway funding the venture along with a visionary CEO, who has a credible and altruistic vision of how health care must change to deliver quality care. 













http://tinyurl.com/y8u86x5q